Massie B - Search Results

1

Deleterious effects of hydralazine in patients with pulmonary hypertension.

Packer M, Greenberg B, Massie B, Dash H. Packer M, et al. Among authors: massie b. N Engl J Med. 1982 Jun 3;306(22):1326-31. doi: 10.1056/NEJM198206033062203. N Engl J Med. 1982. PMID: 7070457

2

Beneficial effects of hydralazine in severe mitral regurgitation.

Greenberg BH, Massie BM, Brundage BH, Botvinick EH, Parmley WW, Chatterjee K. Greenberg BH, et al. Among authors: massie bm. Circulation. 1978 Aug;58(2):273-9. doi: 10.1161/01.cir.58.2.273. Circulation. 1978. PMID: 668075

3

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.

Massie BM, Packer M, Hanlon JT, Combs DT. Massie BM, et al. J Am Coll Cardiol. 1983 Aug;2(2):338-44. doi: 10.1016/s0735-1097(83)80172-7. J Am Coll Cardiol. 1983. PMID: 6345633 Free article.

4

Oral hydralazine therapy for chronic refractory heart failure.

Chatterjee K, Parmley WW, Massie B, Greenberg B, Werner J, Klausner S, Norman A. Chatterjee K, et al. Among authors: massie b. Circulation. 1976 Dec;54(6):879-83. doi: 10.1161/01.cir.54.6.879. Circulation. 1976. PMID: 825327

5

Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.

Greenberg BH, Massie BM. Greenberg BH, et al. Among authors: massie bm. Circulation. 1980 Jun;61(6):1212-6. doi: 10.1161/01.cir.61.6.1212. Circulation. 1980. PMID: 7371134 No abstract available.

6

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.

Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW. Massie B, et al. Am J Cardiol. 1977 Nov;40(5):794-801. doi: 10.1016/0002-9149(77)90199-0. Am J Cardiol. 1977. PMID: 411364

7

Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure?

Haeusslein EA, Greenberg BH, Massie BM. Haeusslein EA, et al. Among authors: massie bm. Chest. 1991 Nov;100(5):1312-5. doi: 10.1378/chest.100.5.1312. Chest. 1991. PMID: 1935287

8

Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial.

Greenberg B, Massie B, Bristow JD, Cheitlin M, Siemienczuk D, Topic N, Wilson RA, Szlachcic J, Thomas D. Greenberg B, et al. Among authors: massie b. Circulation. 1988 Jul;78(1):92-103. doi: 10.1161/01.cir.78.1.92. Circulation. 1988. PMID: 3289791 Clinical Trial.

9

Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study.

Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager MA. Packer M, et al. Among authors: massie bm. J Am Coll Cardiol. 1993 Jul;22(1):65-72. doi: 10.1016/0735-1097(93)90816-j. J Am Coll Cardiol. 1993. PMID: 8509565 Free article. Clinical Trial.

10

Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan.

Massie BM, Shah NB, Pitt B, Packer M. Massie BM, et al. Am Heart J. 1996 Jul;132(1 Pt 1):130-6. doi: 10.1016/s0002-8703(96)90401-9. Am Heart J. 1996. PMID: 8701855 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

584 results

Search Page

Filters